Daniela Brady, FNP
Nurse Practitioners (Family Nurse Practitioner)
- Medicare participating
At a glance
- Years since graduation
- 12
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 30
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Nurse Practitioner primary
NY license F339530
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Westchester Medical Center Advanced Physician Services PC (897 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 30
- Services billed
- 45
- Patients’ average age
- 64
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tadalafil | 157 |
| Ambrisentan | 128 |
| Adempas (riociguat) | 122 |
| Tyvaso Dpi (treprostinil) | 82 |
| Sildenafil Citrate Other prescribers in New York, NY | 71 |
| Furosemide Other prescribers in New York, NY | 69 |
| Opsumit (macitentan) | 68 |
| Uptravi (selexipag) | 53 |
| Warfarin Sodium Other prescribers in New York, NY | 46 |
| Digoxin Other prescribers in New York, NY | 40 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 4 payments worth $169 in total to this clinician.
| Actelion Pharmaceuticals US, Inc. | $98.99 |
|---|---|
| Merck Sharp & Dohme LLC | $51.40 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.28 |
| Education | $169 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. Mar 24, 2025 | Education OPSUMIT; UPTRAVI · Cardiology · in-kind | $98.99 |
| Merck Sharp & Dohme LLC Nov 7, 2025 | Education WINREVAIR · CARDIOVASCULAR · in-kind | $25.70 |
| Merck Sharp & Dohme LLC Nov 7, 2025 | Education WINREVAIR · CARDIOVASCULAR · in-kind | $25.70 |
| Bayer HealthCare Pharmaceuticals Inc. Feb 5, 2025 | Education Adempas · Cardio-pulmonary · in-kind | $18.28 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.